Research Projects & Grants

College/University

  • POEM: A PrOspective Registry of Pediatric Cellular Therapy Patients at risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS), Role: Investigator, Duke University, (11/2025 - 11/2026) Status: Approved
  • A Phase II Intrapatient Open-Label Dose Escalation Trial of Defibrotide in Hematopoietic Cell Transplantation (HCT) Recipients with Sinusoidal Obstructive Syndrome (SOS) Post-HCT Associated with either Renal and/or Pulmonary Dysfunction with Either Refractory or Progressive Disease Following Defibrotide Therapy, Role: Investigator, New York Medical College, (05/2026 - 05/2027) Status: Approved

For Profit Organization

  • Juno Therapeutics JCAR017-EAP-001: Expanded access protocol (EAP) for subjects receiving Lisocabtagene Maraleucel that is nonconforming for commercial release., Role: Investigator, Celgene, Inc., (02/2026 - 02/2027) Status: Approved
  • ALLO-329-101: A Phase 1 Study, Evaluating the Safety and Preliminary Efficacy of ALLO-329, a Dual Anti-CD19/Anti-CD70 Allogenic Car T Cell in Autoimmune Disease, Role: Investigator, Allogene Therapeutics, Inc., (12/2025 - 12/2026) Status: Approved
  • CYTB323J12201: A Phase 2, open-label study to evaluate the efficacy and safety of rapcabtagene autoleucel in patients with active, refractory systemic lupus erythematosus (SLE) or active, refractory lupus nephritis (LN), Role: Investigator, Novartis Pharmaceuticals Corporation, (07/2026 - 07/2027) Status: Approved

Non-Profit Organization

  • National Marrow Donor Program® (NMDP) - 10-CBA: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications, Role: Investigator, National Marrow Donor Program, (08/2026 - 08/2027) Status: Approved
  • NMDP and CIBMTR - Protocol for Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries., Role: Investigator, National Marrow Donor Program, (04/2026 - 04/2027) Status: Approved
  • The National Marrow donor Program (NMDP) and Center for International Blood and Marrow Transplant Research (CIBMTR) - Contribution of a Blood Sample to the National Marrow Donor Program's Research Sample Repository, Role: Investigator, National Marrow Donor Program, (09/2026 - 09/2027) Status: Approved